Abiopharma

🔍 Goldstein Eyal (Executive)

Company: ASURE SOFTWARE INC (ASUR)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 60,000 shares of Asure Software, Inc. Common Stock ($0.01 par value) at $7.86 per share (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 478,017.00 | transaction_form_type: 4
• Sold 54,768 shares of Asure Software, Inc. Common Stock ($0.01 par value) at $9.18 per share (Direct)
  Date: 2026-05-07 | Code: F | equity_swap_involved: 0 | shares_owned_after: 423,249.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 60,000 shares of Employee Stock Option (Right to Buy) at $7.86 per share (Derivative)
  Date: 2026-05-07 | Code: M | Expires: 2026-05-13 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares represent the payment of exercise price and tax liability associated with the exercise of stock options that were originally granted on May 13, 2021.
• F2: Represents grant of employee stock options that vested 1/3rd on the first anniversary of the grant date of May 13, 2021, (the "Grant Date") and the remaining 2/3rds vested over a period of two years in equal monthly installments with the last such vesting date being the third anniversary of the Grant Date.